# Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI

> **NCT02012140** · PHASE4 · UNKNOWN · sponsor: **LifeBridge Health** · enrollment: 200 (estimated)

## Conditions studied

- Cardiovascular Disease
- Stable Angina
- Myocardial Infarction
- Coronary Artery Disease

## Interventions

- **DRUG:** ticagrelor

## Key facts

- **NCT ID:** NCT02012140
- **Lead sponsor:** LifeBridge Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2015-01
- **Final completion:** —
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2013-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02012140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02012140, "Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02012140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*